Top
image: Csaba Deli / Shutterstock

Biomarker predicts kidney cancer risk years before diagnosis

August 17, 2018

The research showed that a protein called KIM-1, which is elevated in the blood of some RCC patients at the time of diagnosis, could also be used as a tool to predict onset of the disease up to five years prior to diagnosis.

Lead investigator Rupal Bhatt (Harvard Medical School) says the study showed a significant association between plasma KIM-1 concentrations and the risk of renal cell carcinoma.

Read More on The Medical News